tiprankstipranks
Cidara Therapeutics (CDTX)
NASDAQ:CDTX
US Market

Cidara Therapeutics (CDTX) Financial Statements

Compare
728 Followers

Cidara Therapeutics Financial Overview

Cidara Therapeutics's market cap is currently $195.19M. The company's EPS TTM is $-29.691; its P/E ratio is ―; Cidara Therapeutics is scheduled to report earnings on March 11, 2025, and the estimated EPS forecast is $-3.54. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 1.27M$ 63.91M$ 64.29M$ 49.57M$ 12.07M
Gross Profit$ -83.61M$ 62.38M$ 64.14M$ 49.38M$ -55.95M
Operating Income$ -176.10M$ -24.48M$ -29.72M$ -42.26M$ -71.85M
EBITDA$ -176.10M$ -24.36M$ -33.36M$ -42.26M$ -71.56M
Net Income$ -169.83M$ -22.93M$ -29.80M$ -43.91M$ -72.37M
Balance Sheet
Cash & Short-Term Investments$ 189.82M$ 35.78M$ 32.73M$ 62.27M$ 35.91M
Total Assets$ 214.80M$ 67.03M$ 47.59M$ 75.33M$ 60.42M
Total Debt$ 3.58M$ 4.88M$ 1.32M$ 5.06M$ 7.96M
Net Debt$ -186.25M$ -30.90M$ -31.41M$ -57.21M$ -27.95M
Total Liabilities$ 51.49M$ 75.24M$ 50.50M$ 53.75M$ 49.71M
Stockholders' Equity$ 163.31M$ -8.21M$ -2.90M$ 21.57M$ 10.71M
Cash Flow
Free Cash Flow$ -176.66M$ -22.94M$ -28.59M$ -25.27M$ -54.60M
Operating Cash Flow$ -176.53M$ -22.43M$ -28.47M$ -25.23M$ -54.41M
Investing Cash Flow$ -129.00K$ -505.00K$ -118.00K$ -41.00K$ -186.00K
Financing Cash Flow$ 337.06M$ 25.98M$ -951.00K$ 44.60M$ 37.28M
Currency in USD

Cidara Therapeutics Earnings and Revenue History

Cidara Therapeutics Debt to Assets

Cidara Therapeutics Cash Flow

Cidara Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis